$0.223800
-0.0006-0.27%
At Close: -
$0.226900
0.00311.39%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Viracta Therapeutics (VIRX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestViracta Therapeutics (NASDAQ:VIRX) Stock Quotes, Forecast and News Summary
Viracta Therapeutics Stock (NASDAQ: VIRX) stock price, news, charts, stock research, profile.
| Open | $0.22 |
| Close | $0.22 |
| Volume / Avg. | 206.92K / 620.19K |
| Day Range | $0.21 - $0.23 |
| 52 Wk Range | 0.20 - 1.31 |
| Market Cap | $8.94M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 32 |
| Short Interest | 4.07% |
| Days to Cover | 1.83 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Viracta Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicine...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Viracta Therapeutics (VIRX) stock?
You can purchase shares of Viracta Therapeutics (NASDAQ:VIRX) through any online brokerage.
Who are Viracta Therapeutics (VIRX) competitors?
Other companies in Viracta Therapeutics’s space includes: Addex Therapeutics (NASDAQ:ADXN), Coeptis Therapeutics (NASDAQ:COEP), Can Fite Biofarma (AMEX:CANF), NuCana (NASDAQ:NCNA) and ABVC BioPharma (NASDAQ:ABVC).
What is the forecast, or price target, for Viracta Therapeutics (VIRX) stock?
Viracta Therapeutics has a consensus price target of $6.17.
What is the current price for Viracta Therapeutics (VIRX)?
The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $0.2269 last updated September 20, 2024 at 4:00 PM EDT.
Does Viracta Therapeutics (VIRX) pay a dividend?
There are no upcoming dividends for Viracta Therapeutics.
When is Viracta Therapeutics (NASDAQ:VIRX) reporting earnings?
Viracta Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Viracta Therapeutics (VIRX) going to split?
There is no upcoming split for Viracta Therapeutics.
What sector and industry does Viracta Therapeutics (VIRX) operate in?
Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.